AAIPharma Services Announces Fixed Budget Pricing Program

Wilmington, NC – February 18, 2010 - AAIPharma Services announces its Fixed Budget Pricing Program.  When you are seeking to develop a new molecular entity into a clinical drug product candidate, keeping the program on budget is becoming as important as keeping it on time.  That’s why there’s AAIPharma Services FBP program to ensure you are on time and on budget – no surprises. 

The program includes:

  • Full drug product development services
  • Fixed budget and milestones
  • No pass through charges (or mark ups)
  • No charges for retesting/investigational work
  • No extra project management fees

 
So, how do you get started?

  • Together, we define the scope in a proposal. The product development services must include analytical, formulation development, manufacturing, stability/QC release testing and packaging.
  • The product must be an immediate release single active solid oral dosage form.
  • AAIPharma’s standard SOPs will be followed.
  • While Fixed Budget Pricing does not include clinical packaging and distribution services, sterile manufacturing, large molecule analysis/testing or regulatory services, these services can be included as a separate project proposal.

 

You face a lot of unknowns in developing your new product.  Keeping it on budget shouldn’t be one of them. 

If this sounds like a program that could work for you or have questions, request more information here: www.aaipharma.com/request-more-info.
 

About AAIPharma Services Corp.
AAIPharma Services Corp. is a leading provider of services that encompass the entire process of pharmaceutical drug development from discovery through commercialization. The company specializes in analytical chemistry, formulation development, clinical packaging, oral drug delivery and contract manufacturing. AAIPharma Services serves more than 300 large pharmaceutical and biotechnology companies throughout North America.  It is headquartered in Wilmington, North Carolina.  For more information on the company, go to www.aaipharma.com.
 
 
Media contact:  Barry Johnson, 800.575.4224, 919.260.6696, barry.johnson@aaipharma.com